Biomarin Pharmaceutical Inc. (BM8)
Market Open
10 Aug, 20:00
€
57. 96
+2.8
+5.0761%
€
9.08B Market Cap
126.18 P/E Ratio
- Div Yield
754 Volume
1 Eps
€ 55.16
Previous Close Want to track BM8 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biomarin Pharmaceutical Inc. (BM8) Statistics
Valuation metrics
Market Cap 9.08B
Enterprise value 15.66B
Trailing P/E (ttm) 167.92
Forward P/E 51.07
PEG ratio -1.89
Price/Sales (ttm) 3.62
Price/Book (mrq) 1.95
Enterprise Value/Revenue 4.6
Enterprise Value/EBITDA 136.02
Overview
Shares outstanding 193.27M
Float 192.17M
Shares short -
% Held by insiders 0%
% Held by institutions 1.03%
Average volume (10 days) 1.24K
Average volume (90 days) 484
Price summary
52-Week low 42.62
52-Week high 57.96
Beta 0.23
50-Day moving average 51.54
200-Day moving average 48.97
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.02%
Operating margin 0.08%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.01%
Income Statement
Revenue (ttm) 2.79B
Revenue per share (ttm) 17.65
Quarterly revenue growth (yoy) 0.03%
Gross profit (ttm) 1.43B
EBITDA 572.94M
Net income to common (ttm) 231.01M
Diluted EPS (ttm) 0.38
Quarterly earnings growth (yoy) -0.43%
Balance Sheet
Total cash (mrq) 1.91B
Total cash per share (mrq) 4.53
Total debt (mrq) 1.24B
Total Debt/Equity (mrq) 0.66
Current ratio (mrq) 2.39%
Book value per share (mrq) 32.76
Cash Flow
Cash flow statement 751.5M
Levered free cash flow (LFCF) 394.91M
